- Iovance Biotherapeutics shares climbed more than 10% in after-hours trading, catching the attention of investors watching the biotech sector.
- Stocktwits reported the move, which came after the market closed on Thursday.
- Traders are digging into the catalysts behind the surge as the stock reacts to fresh news.
- Biotech names like Iovance often swing sharply on clinical updates and regulatory developments.
- Investors will be watching the next session closely to see whether the gains hold.
AI-generated briefing — triage, not the story; every claim links out to the coverage below.
Latest video
Powered by TPD Video
OrgIovance BiotherapeuticsTopicBiotech Stocks
Reader pollAdvertisement
Powered by Sided
The Conversation
